Text Size

Quality of Life and Sexuality in Women With Gynaecological Cancer

This study is not yet open for participant recruitment.
Verified April 2012 by Rambam Health Care Campus
Sponsor:
Information provided by (Responsible Party):
Rambam Health Care Campus
ClinicalTrials.gov Identifier:
NCT01589406
First received: April 29, 2012
Last updated: May 1, 2012
Last verified: April 2012
History of Changes
  Purpose

Patients with premalignant (CIN3) and malignant cervical cancer will asked to complete questionnaires regarding intimacy (ENRICH) and life adaptation (PAIS) before treatment (surgery or radiotherapy) and after completion of treatment in order to estimate the influence of disease and treatment on quality of life indices.


Condition
Cancer

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: Quality of Life and Sexuality in Women With Gynaecological Cancer

Resource links provided by NLM:

MedlinePlus related topics: Cancer
U.S. FDA Resources

Further study details as provided by Rambam Health Care Campus:

Primary Outcome Measures:
  • Quality of life [ Time Frame: 2 years ] [ Designated as safety issue: No ]
    longitudinal describtion of quality of life during treatment


Estimated Enrollment: 100
Study Start Date: June 2012
Estimated Study Completion Date: May 2014
Estimated Primary Completion Date: May 2014 (Final data collection date for primary outcome measure)
Groups/Cohorts
group A group B
A:Patients for surgical intervention B:Patients for radiotherapy

Detailed Description:

no additional information. see above

  Eligibility

Ages Eligible for Study:   18 Years to 70 Years
Genders Eligible for Study:   Female
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

women with Gynaecological cancer

Criteria

Inclusion Criteria:

  • women with Gynaecological cancer intended to undergo chemotherapy or surgery
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT01589406

Locations
Israel
Rambam Medical Center Not yet recruiting
Haifa, Israel
Contact: Amnon Amit, MD     97248543872 ext 3872     a_amit@rambam.health.gov.il    
Contact: Amnon Amit, md     97248543872 ext 3872     a_amit@rambam.health.gov.il    
Sponsors and Collaborators
Rambam Health Care Campus
Investigators
Principal Investigator: Amnon Amit, MD Rambam Health Care Campus
  More Information

No publications provided

Responsible Party: Rambam Health Care Campus
ClinicalTrials.gov Identifier: NCT01589406     History of Changes
Other Study ID Numbers: 538-10CTIL
Study First Received: April 29, 2012
Last Updated: May 1, 2012
Health Authority: Israel: Ministry of Health

Keywords provided by Rambam Health Care Campus:
Gynaecological Cancer
Quality of Life
Sexuality

ClinicalTrials.gov processed this record on June 17, 2013